A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review

A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review

BackgroundDe novo neuroendocrine prostate cancer (NEPC) is a rare subtype of prostate cancer (PCa) and few markers are available for screening and monitoring. Potential circulating or fluid markers might facilitate early diagnosis thus improving prognosis of NEPC, especially for de novo NEPC.Case pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Weizhe Han, Nihati Rexiati, Fang Yu, Yongzhi Wang, Yueli Tian, Jianyuan Wu, Gang Wang, Tao Liu, Zhonghua Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
neuroendocrine prostate cancer (NEPC)
carcinoembryonic antigen (CEA)
homologous recombination repair (HRR)
marker
prostate cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1508410/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items